The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

[18F]FDG     (2R,5R)-3-fluoro-6- (hydroxymethyl)oxane-2...

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of [18F]FDG


Psychiatry related information on [18F]FDG


High impact information on [18F]FDG


Chemical compound and disease context of [18F]FDG


Biological context of [18F]FDG


Anatomical context of [18F]FDG


Associations of [18F]FDG with other chemical compounds


Gene context of [18F]FDG


Analytical, diagnostic and therapeutic context of [18F]FDG


  1. Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. Akhurst, T., Kates, T.J., Mazumdar, M., Yeung, H., Riedel, E.R., Burt, B.M., Blumgart, L., Jarnagin, W., Larson, S.M., Fong, Y. J. Clin. Oncol. (2005) [Pubmed]
  2. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. Sasaki, R., Komaki, R., Macapinlac, H., Erasmus, J., Allen, P., Forster, K., Putnam, J.B., Herbst, R.S., Moran, C.A., Podoloff, D.A., Roth, J.A., Cox, J.D. J. Clin. Oncol. (2005) [Pubmed]
  3. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method. Kuhl, D.E., Metter, E.J., Riege, W.H. Ann. Neurol. (1984) [Pubmed]
  4. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography. Glantz, M.J., Hoffman, J.M., Coleman, R.E., Friedman, A.H., Hanson, M.W., Burger, P.C., Herndon, J.E., Meisler, W.J., Schold, S.C. Ann. Neurol. (1991) [Pubmed]
  5. Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Janus, T.J., Kim, E.E., Tilbury, R., Bruner, J.M., Yung, W.K. Ann. Neurol. (1993) [Pubmed]
  6. Abnormal cerebral glucose metabolism in long-term survivors of childhood acute lymphocytic leukemia. Phillips, P.C., Moeller, J.R., Sidtis, J.J., Dhawan, V., Steinherz, P.G., Strother, S.C., Ginos, J.Z., Rottenberg, D.A. Ann. Neurol. (1991) [Pubmed]
  7. Contrasting metabolic impairment in frontotemporal degeneration and early onset Alzheimer's disease. Ibach, B., Poljansky, S., Marienhagen, J., Sommer, M., Männer, P., Hajak, G. Neuroimage (2004) [Pubmed]
  8. Regional cerebral glucose metabolism in children with deterioration of one or more cognitive functions and continuous spike-and-wave discharges during sleep. Maquet, P., Hirsch, E., Metz-Lutz, M.N., Motte, J., Dive, D., Marescaux, C., Franck, G. Brain (1995) [Pubmed]
  9. Cerebral glucose metabolism in women with panic disorder. Bisaga, A., Katz, J.L., Antonini, A., Wright, C.E., Margouleff, C., Gorman, J.M., Eidelberg, D. The American journal of psychiatry. (1998) [Pubmed]
  10. Metabolic impairment in human amnesia: a PET study of memory networks. Fazio, F., Perani, D., Gilardi, M.C., Colombo, F., Cappa, S.F., Vallar, G., Bettinardi, V., Paulesu, E., Alberoni, M., Bressi, S. J. Cereb. Blood Flow Metab. (1992) [Pubmed]
  11. Functional imaging of endocrine tumors: role of positron emission tomography. Pacak, K., Eisenhofer, G., Goldstein, D.S. Endocr. Rev. (2004) [Pubmed]
  12. Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism. Selberg, O., Burchert, W., vd Hoff, J., Meyer, G.J., Hundeshagen, H., Radoch, E., Balks, H.J., Müller, M.J. J. Clin. Invest. (1993) [Pubmed]
  13. In vivo imaging of neuronal activation and plasticity in the rat brain by high resolution positron emission tomography (microPET). Kornblum, H.I., Araujo, D.M., Annala, A.J., Tatsukawa, K.J., Phelps, M.E., Cherry, S.R. Nat. Biotechnol. (2000) [Pubmed]
  14. [18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability? Srinivasan, G., Kitsiou, A.N., Bacharach, S.L., Bartlett, M.L., Miller-Davis, C., Dilsizian, V. Circulation (1998) [Pubmed]
  15. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. Downey, R.J., Akhurst, T., Ilson, D., Ginsberg, R., Bains, M.S., Gonen, M., Koong, H., Gollub, M., Minsky, B.D., Zakowski, M., Turnbull, A., Larson, S.M., Rusch, V. J. Clin. Oncol. (2003) [Pubmed]
  16. Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography. Chen, D.L., Ferkol, T.W., Mintun, M.A., Pittman, J.E., Rosenbluth, D.B., Schuster, D.P. Am. J. Respir. Crit. Care Med. (2006) [Pubmed]
  17. Brain tumor imaging with PET and 2-[carbon-11]thymidine. Vander Borght, T., Pauwels, S., Lambotte, L., Labar, D., De Maeght, S., Stroobandt, G., Laterre, C. J. Nucl. Med. (1994) [Pubmed]
  18. [18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Perani, D., Colombo, C., Bressi, S., Bonfanti, A., Grassi, F., Scarone, S., Bellodi, L., Smeraldi, E., Fazio, F. The British journal of psychiatry : the journal of mental science. (1995) [Pubmed]
  19. Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease. Mäki, M., Nuutila, P., Laine, H., Voipio-Pulkki, L.M., Haaparanta, M., Solin, O., Knuuti, J.M. Diabetes (1997) [Pubmed]
  20. Images in neuroscience. Neuroimaging, I.PET with [18F]fluorodeoxyglucose. Tamminga, C.A. The American journal of psychiatry. (1995) [Pubmed]
  21. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia. Pietrini, P., Dani, A., Furey, M.L., Alexander, G.E., Freo, U., Grady, C.L., Mentis, M.J., Mangot, D., Simon, E.W., Horwitz, B., Haxby, J.V., Schapiro, M.B. The American journal of psychiatry. (1997) [Pubmed]
  22. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method. Schmidt, K., Lucignani, G., Moresco, R.M., Rizzo, G., Gilardi, M.C., Messa, C., Colombo, F., Fazio, F., Sokoloff, L. J. Cereb. Blood Flow Metab. (1992) [Pubmed]
  23. A physiologic imaging pilot study of breast cancer treated with AZD2171. Miller, K.D., Miller, M., Mehrotra, S., Agarwal, B., Mock, B.H., Zheng, Q.H., Badve, S., Hutchins, G.D., Sledge, G.W. Clin. Cancer Res. (2006) [Pubmed]
  24. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose. Dilsizian, V., Arrighi, J.A., Diodati, J.G., Quyyumi, A.A., Alavi, K., Bacharach, S.L., Marin-Neto, J.A., Katsiyiannis, P.T., Bonow, R.O. Circulation (1994) [Pubmed]
  25. [18F]fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies. Antoine, J.C., Cinotti, L., Tilikete, C., Bouhour, F., Camdessanché, J.P., Confavreux, C., Vighetto, A., Renault-Mannel, V., Michel, D., Honnorat, J. Ann. Neurol. (2000) [Pubmed]
  26. Source propagation of interictal spikes in temporal lobe epilepsy. Correlations between spike dipole modelling and [18F]fluorodeoxyglucose PET data. Merlet, I., Garcia-Larrea, L., Grégoire, M.C., Lavenne, F., Mauguière, F. Brain (1996) [Pubmed]
  27. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Baer, F.M., Voth, E., Schneider, C.A., Theissen, P., Schicha, H., Sechtem, U. Circulation (1995) [Pubmed]
  28. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Gerber, B.L., Vanoverschelde, J.L., Bol, A., Michel, C., Labar, D., Wijns, W., Melin, J.A. Circulation (1996) [Pubmed]
  29. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Breier, A., Malhotra, A.K., Pinals, D.A., Weisenfeld, N.I., Pickar, D. The American journal of psychiatry. (1997) [Pubmed]
  30. Reproducibility of regional brain metabolic responses to lorazepam. Wang, G.J., Volkow, N.D., Overall, J., Hitzemann, R.J., Pappas, N., Pascani, K., Fowler, J.S. J. Nucl. Med. (1996) [Pubmed]
  31. Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine. Tjuvajev, J.G., Macapinlac, H.A., Daghighian, F., Scott, A.M., Ginos, J.Z., Finn, R.D., Kothari, P., Desai, R., Zhang, J., Beattie, B. J. Nucl. Med. (1994) [Pubmed]
  32. [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. Mamede, M., Higashi, T., Kitaichi, M., Ishizu, K., Ishimori, T., Nakamoto, Y., Yanagihara, K., Li, M., Tanaka, F., Wada, H., Manabe, T., Saga, T. Neoplasia (2005) [Pubmed]
  33. Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice. Chung, J.K., Lee, Y.J., Kim, C., Choi, S.R., Kim, M., Lee, K., Jeong, J.M., Lee, D.S., Jang, J.J., Lee, M.C. J. Nucl. Med. (1999) [Pubmed]
  34. Cerebral glucose metabolism in adolescent girls with attention-deficit/hyperactivity disorder. Ernst, M., Cohen, R.M., Liebenauer, L.L., Jons, P.H., Zametkin, A.J. Journal of the American Academy of Child and Adolescent Psychiatry. (1997) [Pubmed]
  35. Glucose metabolism in the rat frontal cortex recovered without the recovery of choline acetyltransferase activity after lesioning of the nucleus basalis magnocellularis. Katsumi, Y., Hayashi, T., Oyanagi, C., Nagahama, Y., Yamauchi, H., Ono, S., Fukuyama, H., Shibasaki, H. Neurosci. Lett. (2000) [Pubmed]
  36. Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation. Spaepen, K., Stroobants, S., Dupont, P., Vandenberghe, P., Maertens, J., Bormans, G., Thomas, J., Balzarini, J., De Wolf-Peeters, C., Mortelmans, L., Verhoef, G. Blood (2003) [Pubmed]
  37. Positron emission tomography studies of cerebral glucose metabolism in chronic partial epilepsy. Abou-Khalil, B.W., Siegel, G.J., Sackellares, J.C., Gilman, S., Hichwa, R., Marshall, R. Ann. Neurol. (1987) [Pubmed]
  38. Brain imaging evidence of preclinical Alzheimer's disease in normal aging. Jagust, W., Gitcho, A., Sun, F., Kuczynski, B., Mungas, D., Haan, M. Ann. Neurol. (2006) [Pubmed]
  39. PET and MRI of the thalamus in never-medicated patients with schizophrenia. Buchsbaum, M.S., Someya, T., Teng, C.Y., Abel, L., Chin, S., Najafi, A., Haier, R.J., Wu, J., Bunney, W.E. The American journal of psychiatry. (1996) [Pubmed]
  40. Cerebral metabolic relationships for selected brain regions in Alzheimer's, Huntington's, and Parkinson's diseases. Metter, E.J., Riege, W.H., Kameyama, M., Kuhl, D.E., Phelps, M.E. J. Cereb. Blood Flow Metab. (1984) [Pubmed]
WikiGenes - Universities